News Teva buys US rights to Celltrion biosimilars Israeli firm buys rights to near-copies of Roche blockbusters.
News Samsung Bioepis files Herceptin biosimilar in EU South Korean firm trying to copy breast cancer blockbuster.
News Amjevita, first Humira biosimilar approved – but no launch y... Amgen's biosimilar is ready to go, but AbbVie believes it can delay until 2022
News Biosimilar junket: Hospira took UK pharmacists to 5-star hot... Hospira trip ruled to be disguised promotion
News Bad news for Sanofi as biosimilar replaces Lantus Pharmacy benefit firm axes Lantus, decision due on key combination therapy.
News Biosimilar switching not suitable for all patients Antibodies against originator will also target biosimilar.
News Isomorphic Labs raises $5bn in massive third round In yet another sign of the appetite for AI companies among investors, Isomorphic Labs has raised a whopping $5bn in a Series C financing.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.